Received Jul 11, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
still had breakthrough chicken pox; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of chickenpox in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced chickenpox (Verbatim: still had breakthrough chicken pox). The outcome of the chickenpox was not reported. It was unknown if the reporter considered the chickenpox to be related to Shingles vaccine. It was unknown if the company considered the chickenpox to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 05-JUL-2025 This case was reported by a patient via interactive digital media. The patient had the shots and still had breakthrough chicken pox.